The global export landscape of blood-grouping reagents is led by China, with a substantial volume of 1.1473 million kilograms. Switzerland and the United States follow, indicating a diverse supplier base. Notable annual growth was recorded by China (6.98%), the UK (6.53%), and Denmark (7.62%). Slovenia's growth surged by 143.31%, contrasted by declines in the Netherlands (-12.31%) and Australia (-29.9%). Over the past five years, varying growth and decline depict a fluctuating market driven by changing demand and health sector developments.
Future trends to watch include technological advancements influencing production processes, potential regulatory changes affecting international trade, and the impact of healthcare policies on reagent demand. The geopolitical climate and emerging markets could also shift the landscape, prompting countries to either bolster or reduce their export volumes in response to economic or healthcare developments.
Top countries in Export of Blood-Grouping Reagents by Country
| # | 10 Countries | Kilograms | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 1,147,300 | 2023 | +4.56% | +6.98% | View data |
| 2 | 2 Switzerland | 1,047,400 | 2023 | +3.87% | +3.03% | View data |
| 3 | 3 United States | 912,370 | 2023 | -4% | -2.5% | View data |
| 4 | 4 United Kingdom | 869,930 | 2023 | +2.27% | +6.53% | View data |
| 5 | 5 Spain | 541,590 | 2023 | +4.1% | +3.97% | View data |
| 6 | 6 Germany | 336,210 | 2023 | +2.09% | +2.67% | View data |
| 7 | 7 France | 190,620 | 2023 | -0.8% | -2.94% | View data |
| 8 | 8 Sweden | 31,480 | 2023 | +5.44% | +5.82% | View data |
| 9 | 9 South Africa | 30,530 | 2023 | +3.68% | +1.45% | View data |
| 10 | 10 Austria | 15,870 | 2023 | +2.3% | +1.91% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
